SecBot SecBot
6-K ·Filed Mar 30, 2026

GLAXF

GSK plc
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001654954-26-002914
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine buyback with no immediate impact on valuation. Monitor the 20-F annual report (filed 6 March 2026) for fundamental performance trends, as buybacks are typically funded from existing cash flow or capital allocation plans.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
GLAXF ▼ -1.58% at T+60d
NEUTRAL call -1.58% · α vs SPY -18.07% · entry $27.25 → $26.82
Entry = T+0 close
Mar 30, 2026
via day close
T+1d
0.00%
call 0.00% · α -2.89%
$27.25
settled 7mo ago
T+5d
-2.57%
call -2.57% · α -6.87%
$26.55
settled 7mo ago
T+20d
-3.12%
call -3.12% · α -15.72%
$26.40
settled 6mo ago
T+60d
-1.58%
call -1.58% · α -18.07%
$26.82
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

GSK plc purchased 340,000 of its ordinary shares on 27 March 2026 at an average price of 2,043.51 GBp per share, as part of its ongoing buyback program. Since the program began on 17 February 2026, the company has bought back 15,541,521 shares. This routine share repurchase reduces the number of shares outstanding and is a standard capital return to shareholders.

Key Facts

  • GSK purchased 340,000 ordinary shares on 27 March 2026
  • Average purchase price was 2,043.51 GBp per share
  • Part of an existing buyback program announced on 17 February 2026
  • Total shares purchased since program start: 15,541,521
  • Shares will be held as Treasury shares

Financial Impact

Approximately £695,000 spent on this purchase (340,000 shares × 2,043.51 GBp)

shares outstandingtreasury stock

Risk Factors

  • Buybacks can be discontinued if financial conditions deteriorate
  • No impact on earnings fundamentals; stock performance will depend on future earnings and pipeline developments

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-002914
Document: 0001654954-26-002914-index-headers.html0001654954-26-002914
Document: 0001654954-26-002914-index.html0001654954-26-002914
Document: 0001654954-26-002914.txt0001654954-26-002914
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
20w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
20w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Closed — Opens Thu (10h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 30, 2026